Variation in TCF7L2 Influences Therapeutic Response to Sulfonylureas
Diabetes2007Vol. 56(8), pp. 2178–2182
Citations Over TimeTop 1% of 2007 papers
Ewan R. Pearson, Louise A. Donnelly, Charlotte H. Kimber, Adrian L. Whitley, Alex S. F. Doney, Mark I. McCarthy, Andrew T. Hattersley, Andrew D. Morris, Colin N.A. Palmer
Abstract
TCF7L2 variants influence therapeutic response to sulfonylureas but not metformin. This study establishes that genetic variation can alter response to therapy in type 2 diabetes.
Related Papers
- → Adiponectin receptors: expression in Zucker diabetic rats and effects of fenofibrate and metformin(2008)34 cited
- → Metformin ameliorates diabetes but does not normalize the decreased GLUT 4 content in skeletal muscle of obese (fa/fa) Zucker rats(1993)26 cited
- → Metformin Restores Responses to Insulin but Not to Growth Hormone in Sprague–Dawley Rats(2002)5 cited
- → COMPARATIVE EFFICACY OF METFORMIN AND SULFONYLUREA IN MONOTHERAPY OR COMBINATION FOR TYPE 2 DIABETES(2020)1 cited
- → The effect of metformin on expression of vaspin mRNA in insulin resistant rats induced by high-fat diet(2012)